Form 4: Select Medical Holdings Director Acquires 10,000 Shares of Common Stock

James S. Ely III, a director of Select Medical Holdings Corp, acquired 10,000 shares of common stock on April 30, 2024, through a grant of restricted stock.

Summary

• On April 30, 2024, James S. Ely III, a director at Select Medical Holdings Corp, acquired 10,000 shares of common stock.
• The acquisition was a grant of restricted stock.
• The restricted stock will vest in full on April 30, 2025, the first anniversary of the grant date, subject to certain exceptions.
• Following the transaction, Ely directly owns 147,639 shares of Select Medical Holdings Corp.
• The transaction was reported on May 1, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but it's a routine grant of restricted stock with a vesting period.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock grant suggests a commitment to the company's long-term success, as the director's compensation is tied to the company's performance until the vesting date.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates